Giant Cell Tumour of the Femoral Neck: A Rare Site Managed by Curettage and Bone Grafting Only

Omar Kirmani¹, Nasir Muzaffar^1, , Mohammad Ehsan¹ and Shamim Ahmad¹

¹Department of Orthopaedics, Hospital for Bone and Joint Surgery, Barzalla, Srinagar, Kashmir, India

Cite this paper:
Omar Kirmani, Nasir Muzaffar, Mohammad Ehsan and Shamim Ahmad. Giant Cell Tumour of the Femoral Neck: A Rare Site Managed by Curettage and Bone Grafting Only. Global Journal of Surgery. 2013; 1(3):22-24. doi: 10.12691/js-1-3-4

Abstract

A giant cell tumor (GCT) is an osteolytic tumor occurring in young adults at the epiphysis or end of the long bone. This occurs after the epiphyseal plate has ossified and longitudinal bone growth is completed. Giant cell tumor is one of the most obscure and intensively examined tumours of bone. Its histogenesis is uncertain, the histology does not predict the clinical outcome and there are still many unanswered questions with regard to both its treatment and prognosis. Giant cell tumor of femoral head or neck is rarely seen in very few patients with accidental diagnosis. The disease affects activities of daily living (e.g. walking stair climbing and housekeeping) ultimately leading to a loss of functional independence. We present here an uncommon site for occurrence of the GCT in the femoral neck, and its subsequent management by joint preservation surgery employing simple curettage of the lesion and bone grafting with no relapse after two years of follow up.

Keywords:
giant cell tumour femur neck curettage bone grafting

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	Zhen, W, Yaotian, H, Songjian, L, Ge, L, Qingliang, W. Giant- cell tumour of bone: The long term results of treatment by curettage and bone cement. J Bone Joint Surg. [Br] 86-B (2):212-216, March 2004.
[2]	Lackman RD, Hosalkar HS, Ogilvie CM, Torbert JT, Fox EJ. Intralesional Curettage for Grades II and III Giant Cell Tumors of Bone. Clin Orthop Rel Res. 438:123-127, Sep 2005.
[3]	HR Durr, M Maier, V Jansson, A Baur, H J Refior. Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone .Eur J Sur Oncology, 1999 Dec; 25(6); 610-8.
[4]	Jaffe HL, Lichtenstein L, Portis RB. GCT of bone, its pathological appearance, grading, supposed variants and treatment. Arch Pathology 1940; 30:993.
[5]	Kulkarni SS, Dogra AS, Bhosle PB. Total hip arthroplasty for giant cell tumour. J Postgrad Med 1996;42: 82-4.
[6]	Bini SA, Gill K, Johnston JO. Giant cell tumors of bone. Curettage and cement reconstruction .Clin Orthop Rel Res.(321): 245-250,July 1995.
[7]	Harrison MH. Robert Jones, Gathorne Girdlestone and excision arthroplasty of the hip. J Bone Joint Surg. Br 87-B (9); 1306, Sep 2005.
[8]	Cannon CP, Lin PP, Lewis VO, Yasko AW. Acetabular outcome after hip hemiartroplasty in patients with tumors. Clin Orthop Rel Res, 20 November 2006.
[9]	Mirra JM Giant cell tumour .Mirra JM editor. Bone tumours, clinical radiological and pathological correlations .vol.2. Philadelphia:lea and febiger ;1989,pp942.
[10]	McDonald DJ, Sim FH, McLeod RA, Dahlin DC. Giant cell tumor of bone. J Bone Joint Surg [Am] 1986; 68-A: 235-42.
[11]	O'Donell RKJ, Springfield DS, Motwani HK et al. Recurrence of giant-cell tumors of long bones after curettage and packing with cement. J Bone Joint Surg[Am]1994;76-A: 1827-33.
[12]	Szendroi, M. Giant cell tumour of bone. J Bone Joint Surg Br 86-B (1):5-12, January 2004.